TTX-381 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-30 in 1mo
ESTIMATED |
READOUT
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and T
Phase 1/2 · Neuronal Ceroid Lipofuscinosis Type 2 |
Tern Therapeutics, LLC | TTX-381 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|